SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Principal Pharmaceuticals & Chemicals outcome of board meeting

29 Jan 2013 Evaluate

Principal Pharmaceuticals & Chemicals has informed that the board of directors of the company at its meeting held on January 25, 2013, has approved the following as the digital and ecommerce business is become a major business activities of the company, the existing name viz. Principal Pharmaceuticals & Chemicals, needs to be changed to convey the activities of the company. Hence, in the meeting, the board of directors of the company has decided to change the name of the company from Principal Pharmaceuticals & Chemicals to iStreet Network, subject to availability from registrar of companies and approval from members and other authorities as may be required.

The above information is a part of company’s filings submitted to BSE.

iStreet Network Share Price

48.43 0.94 (1.98%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×